CLINICAL VALUE OF MONOSOMAL KARYOTYPE AND COMPLEX KARYOTYPE AS PROGNOSTIC PARAMETER IN PATIENTS WITH IPSS INTERMEDIATE-2 AND HIGH RISK MYELODYSPLASTIC SYNDROMES TREATED WITH AZACITIDINE

被引：0
|
作者：
Song, M. K. [1 ]
Chung, J. S. [1 ]
Moon, J. H. [2 ]
Ahn, J. S. [3 ]
Song, I. C. [4 ]
Hong, J. [5 ]
Lee, G. W. [6 ]
Shin, H. J. [1 ]
机构：
[1] Pusan Natl Univ Hosp, Pusan, South Korea
[2] Kyungpook Natl Univ Hosp, Taegu, South Korea
[3] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea
[4] Chungnam Nast Ujnvers Hosp, Taejon, South Korea
[5] Gachon Univ, Gil Med Ctr, Inchon, South Korea
[6] Gyeong Sang Natl Univ Hosp, Jinju, South Korea
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P922
引用
收藏
页码：346 / 346
页数：1
相关论文
共 50 条
  • [1] The Prognostic Value of Monosomal Karyotype (MK) in High-Risk Patients with Myelodysplastic Syndromes Treated with 5-Azacitidine
    Papageorgiou, Sotirios
    Kontos, Christos K.
    Tsiambalis, Thomas
    Vyniou, Athina
    Symeonidis, Argiris
    Galanopoulos, Athanasios
    Kotsianidis, Ioannis
    Pappa, Vassiliki
    BLOOD, 2017, 130
  • [2] Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
    Itzykson, R.
    Thepot, S.
    Eclache, V.
    Quesnel, B.
    Dreyfus, F.
    Beyne-Rauzy, O.
    Turlure, P.
    Vey, N.
    Recher, C.
    Boehrer, S.
    Gardin, C.
    Ades, L.
    Fenaux, P.
    LEUKEMIA, 2011, 25 (07) : 1207 - 1209
  • [3] Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
    R Itzykson
    S Thépot
    V Eclache
    B Quesnel
    F Dreyfus
    O Beyne-Rauzy
    P Turlure
    N Vey
    C Recher
    S Boehrer
    C Gardin
    L Adès
    P Fenaux
    Leukemia, 2011, 25 : 1207 - 1209
  • [4] Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes
    Takeda, June
    Kawabata, Hiroshi
    Aoki, Kazunari
    Shiga, Shuichi
    Kawahara, Masahiro
    Kitawaki, Toshio
    Hishizawa, Masakatsu
    Kondo, Tadakazu
    Kitano, Toshiyuki
    Yonetani, Noboru
    Tabata, Sumie
    Hiramoto, Nobuhiro
    Matsushita, Akiko
    Hashimoto, Hisako
    Ishikawa, Takayuki
    Kadowaki, Norimitsu
    Takaori, Akifumi
    BLOOD, 2014, 124 (21)
  • [5] Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes
    Gangat, Naseema
    Patnaik, Mrinal M.
    Begna, Kebede
    Kourelis, Taxiarchis
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Hodnefield, Janice M.
    Hanson, Curtis A.
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (08) : 690 - 693
  • [6] The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group
    Papageorgiou, Sotirios G.
    Vasilatou, Diamantina
    Kontos, Christos K.
    Kotsianidis, Ioannis
    Symeonidis, Argiris
    Galanopoulos, Athanasios G.
    Hatzimichael, Eleftheria
    Megalakaki, Aekaterini
    Poulakidas, Elias
    Diamantopoulos, Panagiotis
    Vassilakopoulos, Theodoros P.
    Zikos, Panagiotis
    Papadaki, Helen
    Mparmparousi, Despoina
    Bouronikou, Eleni
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    Pappa, Vassiliki
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 895 - 901
  • [7] Prognostic impact of a monosomal Karyotype in high-grade myelodysplastic syndromes treated by Azacytidine
    Saada, Veronique
    HEMATOLOGIE, 2011, 17 (05): : 312 - 313
  • [8] Monosomal karyotype predicts inferior survival independently of a complex karyotype in patients with myelodysplastic syndromes
    McQuilten, Zoe K.
    Sundararajan, Vijaya
    Andrianopoulos, Nick
    Curtis, David J.
    Wood, Erica M.
    Campbell, Lynda J.
    Wall, Meaghan
    CANCER, 2015, 121 (17) : 2892 - 2899
  • [9] Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine
    Cluzeau, Thomas
    Mounier, Nicolas
    Karsenti, Jean-Michel
    Richez, Valentine
    Legros, Laurence
    Gastaud, Lauris
    Garnier, Georges
    Re, Daniel
    Montagne, Nathalie
    Gutnecht, Jean
    Fuzibet, Jean Gabriel
    Auberger, Patrick
    Raynaud, Sophie
    Cassuto, Jill-Patrice
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (09) : 780 - 783
  • [10] Stratification with monosomal karyotype improves prognostic value of IPSS-R in MDS patients treated with AZA
    Cluzeau, T.
    Mounier, N.
    Karsenti, J. M.
    Gastaud, L.
    Garnier, G.
    Re, D.
    Gutnecht, J.
    Montagne, N.
    Raynaud, S.
    Cassuto, J. P.
    LEUKEMIA RESEARCH, 2013, 37 : S80 - S80
12345